Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof
Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
05/2003
05/22/2003US20030095986 Production of a parvovirus vaccine in plants as viral coat protein fusions
05/22/2003US20030095984 Vaccine against mumps containing a Jeryl-Lynn virus strain
05/22/2003US20030095948 Lentiviral vector construct for transferring nucleotide sequences; comprises transcription regulatory sequences of one or more genes preferentially expressed in endothelial cells of mammals.
05/22/2003CA2756866A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/22/2003CA2473141A1 Macroporous gel, its preparation and its use
05/22/2003CA2465868A1 A method of detecting and/or identifying adeno-associated virus (aav) sequences and isolating novel sequences identified thereby
05/21/2003WO2004041156A2 Method for determining sensitivity to a bacteriophage
05/21/2003EP1312679A1 Recombinant MVA virus, and the use thereof
05/21/2003EP1312678A1 Recombinant MVA virus, and the use thereof
05/21/2003EP1311694A1 Pyruvate:nadp+ oxidoreductase and uses thereof
05/21/2003EP1311686A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
05/21/2003EP1311289A2 Vaccines containing ribavirin and methods of use thereof
05/21/2003EP0877752B1 Methods for screening for transdominant effector peptides and rna molecules
05/21/2003CN1419605A Method of concentrating and recovering a viral enzyme activity from biological samples
05/21/2003CN1418951A Production for RNA virus and RNA virus based carrier granular composition and productive method thereof
05/21/2003CN1109105C Genetically engineered virus of Chinese ballworm
05/21/2003CA2474159A1 Method for determining sensitivity to a bacteriophage
05/20/2003US6566513 Nucleotide sequences coding polypeptide for use as viricide
05/20/2003US6566128 Generation of preferential expression vectors; obtain cells, transform with adenoviral vector, propagate and recover adenovirus virions
05/20/2003US6566118 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles
05/20/2003US6566117 Immortal cell line derived from grouper Epinephelus coioides and its applications therein
05/20/2003US6566093 Alphavirus cDNA vectors
05/20/2003US6565857 Coding human leukocyte antigen; anticancer, antitumor agent
05/20/2003US6565853 Induction immunology response; genetic engineering
05/20/2003CA2223579C Novel recombinant temperature sensitive mutants of influenza
05/20/2003CA2102302C Recombinant defective adenoviruses expressing cytokines for an antitumoral treatment
05/15/2003WO2003040356A1 The intact hepatitis c virus and the method for culturing it in a vitro cell culture
05/15/2003WO2003040305A2 Porcine adenovirus e1 and e4 regions
05/15/2003WO2003040164A2 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003WO2003039593A1 Fowl adenovirus vaccine
05/15/2003WO2003039477A2 Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding
05/15/2003WO2003039459A2 Viral vector production methods and compositions
05/15/2003WO2003039458A2 TREATMENT OF HUMAN CANCER WITH ADENOVIRAL VECTOR EXPRESSING TNF-α
05/15/2003WO2003039225A2 Antigen arrays comprising rankl for treatment of bone disease
05/15/2003WO2001071309A3 Methods and reagents for regulation of cellular responses in biological systems
05/15/2003US20030092882 Host cells containing multiple integrating vectors
05/15/2003US20030092645 Cloning, expression, viral and delivery vectors and hosts
05/15/2003US20030092161 Compositions and methods for production of recombinant viruses, and uses therefor
05/15/2003US20030092134 Nucleic acid encoding 3'-5' exonuclease of bacteriophage RM 378
05/15/2003US20030092128 Nucleotide squences coding polypeptide for use in the textile and fabric treatment
05/15/2003US20030092084 EBV-infected stomach cancer cell line
05/15/2003US20030091985 Cloned DNA sequences related to the entire genomic RNA of human immunodeficiency virus II (HIV-2), polypeptides encoded by these DNA sequences and use of these DNA clones and polypeptides in diagnostic kits
05/15/2003US20030091595 West nile vaccine
05/15/2003US20030091594 CD4-independent HIV envelope proteins as vaccines and therapeutics
05/15/2003US20030091592 Inducting immunology response
05/15/2003US20030091590 Recombinant rhabdoviruses as live-viral vaccines
05/15/2003US20030091537 Anticancer agents; gene coding immunomoderator cytokine protein
05/15/2003US20030091535 Mutant virus with defective genome; genetic engineering
05/15/2003CA2466492A1 Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases
05/15/2003CA2465981A1 Antigen arrays comprising rankl for treatment of bone disease
05/15/2003CA2465361A1 Treatment of human cancer with adenoviral vector expressing tnf-.alpha.
05/14/2003EP1310571A2 A Method of detecting and/or identifying adeno-associated virus (AVV) sequences and isolating novel sequences identified thereby
05/14/2003EP1310552A2 Posh nucleic acids, polypeptides and related methods
05/14/2003EP1310551A1 Virus-like micrograins and process for producing the same
05/14/2003EP1309716A2 A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis
05/14/2003EP1309680A2 Dna & protein binding miniature proteins
05/14/2003EP1309672A1 Method of producing infectious reovirus
05/14/2003EP1309617A2 Process for the selection of hiv-1 subtype c isolates, selected hiv-1 subtype isolates, their genes and modifications and derivatives thereof
05/14/2003EP1309342A2 Production of chimeric human papillomavirus
05/14/2003EP0437604B1 Recombinant poxvirus and streptococcal m protein vaccine
05/14/2003CN1418255A Herpes virus strains for gene therapy
05/14/2003CN1418248A Altered strain of modified vaccinia virus ankara (MVA)
05/14/2003CN1108375C Method for continuous producing protein using recombined phage in membrane bioreactor
05/13/2003US6562617 Library of fusion nucleic acids for use as diagnostic tools in genetic engineering
05/13/2003US6562597 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
05/13/2003US6562586 Screening compound for use a viricides; obtain virally infected sample, monitor activity and gene expression, incubate with viricide, monitor adjustment in viral gene expression and activity, adjustment in activity indicates
05/13/2003US6562350 Combined vaccine against both HAV and measles virus and method of producing it
05/13/2003US6562349 Otitis media vaccine
05/13/2003US6562343 Compositions and methods for the treatment and diagnosis of immune disorders
05/13/2003US6562334 Canine interleukin 12 administration as an immune disease treatment
05/09/2003CA2406687A1 Chimeric promoters for controlling expression in muscle cells
05/08/2003WO2003038119A1 A process for detecting foot-and-mouth disease virus and a kit therefore
05/08/2003WO2003038057A2 Genetic vaccine against human immunodeficiency virus
05/08/2003WO2003037260A2 Methods and compositions for treating parkinson's disease
05/08/2003WO2002095023A3 Replicons derived from positive strand rna virus genomes useful for the production of heterologous proteins
05/08/2003WO2002091994A3 Composition and method for increasing cell density in cell cultures infected with lentivirus
05/08/2003US20030087420 Transgenic animals and cells expressing proteins necessary for susceptibility to HIV infection
05/08/2003US20030087419 Transgenic cell for use in the packaging and controlling expression of viral or heterologous nucleotide sequences >>> TITLE
05/08/2003US20030087418 Detection; cell differentiation; sensitivity to cell microbiocides, parasites
05/08/2003US20030087417 Newcastle disease virus infectious clones, vaccines and diagnostic assays
05/08/2003US20030087393 Endostatin for use in the treatment of cancer and tumor metastasis
05/08/2003US20030087392 Nucleic acid encoding DNA polymerase of bacteriophage RM 378
05/08/2003US20030087284 Virus-binding particles, virus-separating reagent, separation of viruses, and detection of viruses
05/08/2003US20030087264 Detection of regulatory response to pulsatile electromagnetic stimulus; obtain tissue sample, insert probe, apply pulsatile stimulus, detect gene expression, classify genes which are expresed
05/08/2003US20030086945 Porcine reproductive and respiratory syndrome virus and methods of use
05/08/2003US20030086919 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
05/08/2003US20030086904 Therapeutic regimen for treating cancer
05/08/2003US20030086903 Therapeutic regimen for treating cancer
05/08/2003CA2465037A1 Genetic vaccine against human immunodeficiency virus
05/08/2003CA2464887A1 Methods and compositions for treating parkinson's disease
05/07/2003EP1308521A1 A process for detecting foot-and-mouth disease virus and a kit therefor
05/07/2003EP0836648B1 Recombinant mva virus, and the use thereof
05/07/2003CN1416471A Recombinant rhabdoviruses as Live-Viral vaccines for immunodoeficiency viruses
05/07/2003CN1416465A Protecting molecules in biologically derived compsns.while treating with broad-spectrum pulsed light
05/07/2003CN1416463A Diagnostic reagents and methods for antibody against hepatitis B surface antigen and for antibody against hepatitis B Virus
05/06/2003US6559359 Plant extression vector for use as efficient gene transfer tool in genetic engineering
05/06/2003US6558676 Immunizing mammal with noninfectious material and isolating antibodies produced
05/06/2003US6558675 Mutant human hepatitis B viral strain and uses thereof
05/06/2003US6557296 Nucleic acid molecule or fragment thereof that encodes a truncated Nef protein comprising a nucleic acid sequence that encodes substantially the same sequence of amino acid residues 1 through 56 of an HIV-1 Nef protein; treatment of htlv
05/02/2003EP1305438A1 Improved virus like particles based on small envelope protein from hepatitis b (hbsag-s)
1 ... 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 ... 267